Policy● Neutral for Indian equities
Centre may seek legal view on licensing of sterile drugs
The brief
- Government is exploring central licensing authority over all sterile drug products after a Supreme Court decision
- Expanded central licensing could affect Indian pharmaceutical companies making sterile drugs
- India Top Court Questions Election Body Over Voter Roll Changes
- ExxonMobil and Suncor ask US Supreme Court to block climate damages claims
- Hospital stocks: can strong demand offset regulatory risks?
- Hospital stocks sell-off a buying opportunity or a risk? Here is what analysts advice
- Supreme Court flags hospital cancer-drug markups; hospital stocks lose $2.6 billion